High mobility group nucleosomal binding domain 2 pseudogene 48 (HMGN2P48)

HMGN2P48 is a predicted pseudogene corresponding to the parental High mobility group nucleosomal binding domain 2 (HMGN2) gene. Pseudogenes are DNA sequences homologous to known genes but are generally incapable of encoding a functional protein product. While some pseudogenes in the wider HMG (high mobility group) family have been implicated in gene regulation, cancer, or other disease mechanisms via their RNA transcripts, there is no evidence in the scientific literature that HMGN2P48 encodes protein, regulates other genes, or plays a role in disease. As such, HMGN2P48 is not a validated or actionable therapeutic target, nor is it associated with any drugs or clinical biomarkers.

None. No drug targets this entity, and no mechanism of action is established for therapy.